SCHEMBL8913937

SCHEMBL8913937

O=C(Cl)C(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6375136 0.73
SCHEMBL9333820 0.72 OR51E2 (0.59)
SCHEMBL14564211 0.72 OR51E2 (0.59)
SCHEMBL9307587 0.72 OR51E2 (0.59)
SCHEMBL4331467 0.71 OR51E2 (0.50)
SCHEMBL2512864 0.71 CA4 (0.52)
SCHEMBL7502708 0.71
SCHEMBL27777669 0.71
SCHEMBL30848875 0.71
SCHEMBL1765577 0.69 OR51E2 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672757-A ANTITUMOR AGENTS OHGEN RESEARCH LABORATORIES, LTD. (JP) 1997-09-30 US disclosed
US-5523320-A FOR TREATMENT OF LEUKEMIA OHGEN RESEARCH LABORATORIES, LTD. (JP) 1996-06-04 US disclosed
EP-0493064-B1 Deacetylcolchicine derivatives OHGEN RESEARCH LAB LTD (JP) 1995-02-15 EP disclosed
EP-0607647-A1 N-Methyldeacetylcolchiceinamide derivatives OHGEN RESEARCH LABORATORIES LTD., (JP) 1994-07-27 EP disclosed
US-5220002-A Antitumor agents OHGEN RESEARCH LABORATORIES, LTD. (JP) 1993-06-15 US disclosed
EP-0493064-A1 Deacetylcolchicine derivatives OHGEN RESEARCH LABORATORIES LTD., (JP) 1992-07-01 EP disclosed